| 000 | 01070 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514023254.0 | ||
| 264 | 0 | _c20020520 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0108-2701 | ||
| 024 | 7 |
_a10.1107/s0108270101019655 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVega, Daniel | |
| 245 | 0 | 0 |
_aDisodium pamidronate. _h[electronic resource] |
| 260 |
_bActa crystallographica. Section C, Crystal structure communications _cFeb 2002 |
||
| 300 |
_am77-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBone Diseases _xdrug therapy |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aDiphosphonates _xchemistry |
| 650 | 0 | 4 | _aHydrogen Bonding |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aPamidronate |
| 700 | 1 | _aFernández, Daniel | |
| 700 | 1 | _aEllena, Javier A | |
| 773 | 0 |
_tActa crystallographica. Section C, Crystal structure communications _gvol. 58 _gno. Pt 2 _gp. m77-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1107/s0108270101019655 _zAvailable from publisher's website |
| 999 |
_c11737586 _d11737586 |
||